Henrik Frederiksen

Medicine & Life Sciences

1. Idiopathic Thrombocytopenic Purpura 100%
2. Cohort Studies 82%
3. B-Cell Chronic Lymphocytic Leukemia 78%
4. Denmark 71%
5. Population 64%
6. Lymphoma, Large B-Cell, Diffuse 53%
7. Neoplasms 51%
8. Lymphoma 41%
9. Survival 36%
10. Autoimmune Haemolytic Anaemia 36%
11. Registries 35%
12. Confidence Intervals 33%
13. Mortality 30%
14. SARS Virus 30%
15. Multiple Myeloma 30%
16. Comorbidity 30%
17. Evans Syndrome 29%
18. Essential Thrombocythemia 28%
19. Polycythemia Vera 27%
20. Quality of Life 25%
21. Therapeutics 24%
22. Platelet Count 24%
23. Hand Strength 23%
24. Rituximab 22%
25. Incidence 22%
26. Hemorrhage 20%
27. Primary Myelofibrosis 20%
28. Cardiovascular Diseases 20%
29. Acute Myeloid Leukemia 20%
30. Hemolysis 18%
31. Twins 18%
32. Elderly 18%
33. Hodgkin Disease 17%
34. Longitudinal Studies 17%
35. Myelodysplastic Syndromes 17%
36. PCI 32765 17%
37. Serum Albumin 17%
38. Systematic Reviews 16%
39. Hematologic Neoplasms 16%
40. Survivors 15%
41. Haemolytic Anaemia 15%
42. Essential Tremor 15%
43. Thrombotic Thrombocytopenic Purpura 15%
44. Blood Platelets 14%
45. C-Reactive Protein 14%
46. Platelet Aggregation 14%
47. Pandemics 13%
48. Delivery of Health Care 13%
49. Priapism 13%
50. Norway 13%